β¨ Medicines and Company Vesting Notices
NEW ZEALAND GAZETTE, No. 61 β 7 JULY 2016
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Diprivan
Propofol 10mg/mL
Emulsion for injection
AstraZeneca Limited
Fresenius Kabi AB, Uppsala, Sweden
Corden Pharma SpA, Milan, Italy
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Diprivan
Propofol 20mg/mL
Emulsion for injection
AstraZeneca Limited
Corden Pharma SpA, Milan, Italy
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Eylea
Aflibercept 40mg/mL
Solution for injection
Bayer New Zealand Limited
Regeneron Pharmaceuticals Inc, New York, United States of America
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Galvus Met
Metformin hydrochloride 850mg
Vildagliptin 50mg
Film coated tablet
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland
Novartis Pharma Produktions GmbH, Wehr, Germany
Novartis Singapore Pharmaceutical Manufacturing Pte Ltd, Tuas, Singapore
Product:
Active Ingredients:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
Galvus Met
Metformin hydrochloride 1000mg
Vildagliptin 50mg
Film coated tablet
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland
Novartis Pharma Produktions GmbH, Wehr, Germany
Novartis Singapore Pharmaceutical Manufacturing Pte Ltd, Tuas, Singapore
Dated this 30th day of June 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go3848
Notice of Vesting of Property Under Section 324 of the Companies Act 1993
βNew Zealand Parachute Industry Association Limited
I, William Henry David More, Senior Solicitor, acting under delegated authority from the Secretary to the Treasury, hereby give notice that on 1 July 2016 I first became aware that the Crown was vested under section 324 of the Companies Act 1993 with eight parcels of Ordinary B Shares in New Zealand Parachute Industry Association Limited. The shares were vested in the Crown by virtue of the removal from the Companies Register of the companies that formerly held the shares. The parcels of shares, the companies that formerly held the shares, and the dates the companies were removed from the Companies Register are shown in the table below.
| Number of Ordinary B Shares | Struck-off Company which held the Shares | Date Company Struck off the Companies Register |
|---|---|---|
| 1 | Adventure Skydive Limited | 27 January 2012 |
| 2 | Kerikeri Dairies Limited | 18 April 2012 |
| 2 | Parachute Experience Limited | 31 March 2009 |
| 8 | Pokeno Dairies Limited | 30 May 2011 |
64
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare30 June 2016
Medicines, Distribution, Propofol, Aflibercept, Metformin, Vildagliptin
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
βοΈ Notice of Vesting of Property Under Section 324 of the Companies Act 1993
βοΈ Justice & Law EnforcementCompany Vesting, Shares, Companies Act 1993, New Zealand Parachute Industry Association Limited
- William Henry David More, Senior Solicitor
NZ Gazette 2016, No 61